Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study
Yan Gao(Sun Yat-sen University), Huiqiang Huang(Sun Yat-sen University)
Cited by 32
Related Papers
Comparison of Quantitative and Qualitative Tests for Glucose-6-Phosphate Dehydrogenase Deficiency
|American Journal of Tropical Medicine and Hygiene|2014|112